XTANT MEDICAL HOLDINGS, INC. Business Acquisition, Pro Forma Revenue
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Business Acquisition, Pro Forma Revenue of $125.95 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2024-11-12
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $28.11M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $29.65M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-06-30 was $33.56M, a 119.68% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2023-03-31 was $34.63M, a 109.24% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2023 was $125.95M, a 9.83% decline from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2022 was $139.69M.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2016 was $90.00M, a 4.03% increase from fiscal 2015.
- XTANT MEDICAL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2015 was $86.52M, a 11.42% increase from fiscal 2014.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $28.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $57.76M derived: sum of 2 quarters · filed 2024-11-12 | $91.32M derived: sum of 3 quarters · filed 2024-11-12 | $125.95M 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $29.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $63.21M derived: sum of 2 quarters · filed 2024-11-12 | $97.84M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $33.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $68.19M 10-Q · filed 2024-08-08 | $40.00M 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | $34.63M 10-Q · filed 2024-05-15 | $19.77M 10-Q · filed 2023-05-04 | ||||
| 2022-12-31 | $139.69M 10-K · filed 2024-04-01 | |||||
| 2022-06-30 | $15.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $31.83M 10-Q · filed 2023-08-01 | ||||
| 2022-03-31 | $16.55M 10-Q · filed 2023-05-04 | |||||
| 2016-12-31 | $24.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $47.56M derived: sum of 2 quarters · filed 2017-03-29 | $69.03M derived: sum of 3 quarters · filed 2017-03-29 | $90.00M 10-K · filed 2017-03-29 | ||
| 2016-09-30 | $23.09M 10-Q · filed 2016-11-10 | $44.56M derived: sum of 2 quarters · filed 2016-11-10 | $65.53M 10-Q · filed 2016-11-10 | $87.65M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2016-06-30 | $21.46M 10-Q · filed 2016-08-10 | $42.18M 10-Q · filed 2016-08-10 | $64.56M derived: sum of 3 quarters · filed 2017-03-29 | $85.46M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2016-03-31 | $20.98M 10-Q · filed 2016-05-11 | $43.09M derived: sum of 2 quarters · filed 2017-03-29 | $64.00M derived: sum of 3 quarters · filed 2017-03-29 | $85.72M derived: sum of 4 quarters · filed 2017-03-29 | ||
| 2015-12-31 | $22.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $43.02M derived: sum of 2 quarters · filed 2017-03-29 | $64.75M derived: sum of 3 quarters · filed 2017-03-29 | $86.52M 10-K · filed 2017-03-29 | ||
| 2015-09-30 | $20.90M 10-Q · filed 2016-11-10 | $42.63M derived: sum of 2 quarters · filed 2016-11-10 | $64.40M 10-Q · filed 2016-11-10 | $83.87M derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $21.73M 10-Q · filed 2016-08-10 | $43.35M 10-Q · filed 2016-08-10 | $62.97M derived: sum of 3 quarters · filed 2016-08-10 | $82.59M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | $21.73M 10-Q · filed 2016-05-11 | $41.24M derived: sum of 2 quarters · filed 2016-05-11 | $60.86M derived: sum of 3 quarters · filed 2016-05-11 | |||
| 2014-12-31 | $19.52M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $39.13M derived: sum of 2 quarters · filed 2016-03-24 | $77.65M 10-K · filed 2016-03-24 | |||
| 2014-09-30 | $19.62M 10-Q · filed 2015-11-16 | $58.14M 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |